Frey FJ - Search Results

1

Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.

Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A. Arampatzis S, et al. Among authors: frey fj. J Mol Endocrinol. 2005 Aug;35(1):89-101. doi: 10.1677/jme.1.01736. J Mol Endocrinol. 2005. PMID: 16087724

2

Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+.

Arnold P, Tam S, Yan L, Baker ME, Frey FJ, Odermatt A. Arnold P, et al. Among authors: frey fj. Mol Cell Endocrinol. 2003 Mar 28;201(1-2):177-87. doi: 10.1016/s0303-7207(02)00304-0. Mol Cell Endocrinol. 2003. PMID: 12706305

3

Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors.

Lanz B, Kadereit B, Ernst S, Shojaati K, Causevic M, Frey BM, Frey FJ, Mohaupt MG. Lanz B, et al. Among authors: frey bm, frey fj. Kidney Int. 2003 Sep;64(3):970-7. doi: 10.1046/j.1523-1755.2003.00192.x. Kidney Int. 2003. PMID: 12911547 Free article.

4

Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.

Nashev LG, Chandsawangbhuwana C, Balazs Z, Atanasov AG, Dick B, Frey FJ, Baker ME, Odermatt A. Nashev LG, et al. Among authors: frey fj. PLoS One. 2007 Jun 27;2(6):e561. doi: 10.1371/journal.pone.0000561. PLoS One. 2007. PMID: 17593962 Free PMC article.

5

A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.

Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN, Repetto H, Frey BM, Frey FJ, Ferrari P. Odermatt A, et al. Among authors: frey bm, frey fj. J Clin Endocrinol Metab. 2001 Mar;86(3):1247-52. doi: 10.1210/jcem.86.3.7334. J Clin Endocrinol Metab. 2001. PMID: 11238516

6

The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2.

Odermatt A, Arnold P, Frey FJ. Odermatt A, et al. Among authors: frey fj. J Biol Chem. 2001 Jul 27;276(30):28484-92. doi: 10.1074/jbc.M100374200. Epub 2001 May 11. J Biol Chem. 2001. PMID: 11350956 Free article.

7

Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor.

Stauffer AT, Rochat MK, Dick B, Frey FJ, Odermatt A. Stauffer AT, et al. Among authors: frey fj. J Biol Chem. 2002 Jul 19;277(29):26286-92. doi: 10.1074/jbc.M201556200. Epub 2002 May 15. J Biol Chem. 2002. PMID: 12015312 Free article.

8

The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist.

Rebuffat AG, Tam S, Nawrocki AR, Baker ME, Frey BM, Frey FJ, Odermatt A. Rebuffat AG, et al. Among authors: frey bm, frey fj. Mol Cell Endocrinol. 2004 Feb 12;214(1-2):27-37. doi: 10.1016/j.mce.2003.11.027. Mol Cell Endocrinol. 2004. PMID: 15062542

9

Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.

Frey FJ, Odermatt A, Frey BM. Frey FJ, et al. Among authors: frey bm. Curr Opin Nephrol Hypertens. 2004 Jul;13(4):451-8. doi: 10.1097/01.mnh.0000133976.32559.b0. Curr Opin Nephrol Hypertens. 2004. PMID: 15199296 Review.

10

Extracellular ATP determines 11beta-hydroxysteroid dehydrogenase type 2 activity via purinergic receptors.

Kadereit B, Fustier P, Shojaati K, Frey BM, Frey FJ, Mohaupt MG. Kadereit B, et al. Among authors: frey bm, frey fj. J Am Soc Nephrol. 2005 Dec;16(12):3507-16. doi: 10.1681/ASN.2005010108. Epub 2005 Oct 26. J Am Soc Nephrol. 2005. PMID: 16251242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters